Full Text
The Full Text of this article is available as a PDF (87.8 KB).
. 2005 Jan 1;5(1):16–19. doi: 10.7861/clinmedicine.5-1-16
Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm
Jeffrey K Aronson
1
Jeffrey K Aronson, DPhil FRCP
1Oxford Radcliffe Hospitals Trust
Consultant Physician and Clinical Pharmacologist
Find articles by Jeffrey K Aronson
1Oxford Radcliffe Hospitals Trust
Roles
Jeffrey K Aronson: DPhil FRCP, Consultant Physician and Clinical Pharmacologist
Key Words: benefit-to-harm balance, dosage regimens, monitoring drug therapy
© 2005 Royal College of Physicians
PMCID: PMC4954058 PMID: 15745191